Last updated: 2026-10-19 22:19:00. Prices reflect the latest after-hours trading data. Stock price data is sourced from Massive.
Mannkind Corporation (MNKD) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $3.09, with a market capitalization of $977.50M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $2.23 to $6.51. This page covers its latest market performance, valuation, price trends and company information.
$977.50M | |
$3.18 | |
$121.55 | |
$0.67 | |
$3.04 | |
1.91M | |
4.56M | |
-- | |
$6.51 | |
$2.23 | |
-- | |
-- |
Mannkind Corporation (MNKD) is trading at $3.09 in after-hours trading as of 2026-10-19 20:16:00, up 1.48% ($0.04) from the regular-session close of $3.04.
After-hours trading shows how investors are pricing MNKD after the regular session closes. The current after-hours price is above the regular-session close, indicating positive after-hours sentiment.
Over the past seven days, Mannkind Corporation (MNKD) moved from $3.42 to $3.09, representing a decline of 9.80% ($0.33).
The stock traded between $2.90 and $3.53 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 4.53 million shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 20.0%
MNKD is currently trading at $3.09, placing it 20.0% of the way from its 52-week low of $2.23 to its 52-week high of $6.51. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
MannKind Corp is a biopharmaceutical company dedicated to transforming chronic disease care through patient-centric solutions. Focused on cardiometabolic and orphan lung diseases, it develops and commercializes treatments that address unmet medical needs, including diabetes, pulmonary hypertension, and fluid overload in heart failure and chronic kidney disease.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 592 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Mannkind Corporation (MNKD) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.